title: Pulmonary rehabilitation improves exercise capacity and dyspnea in air pollution-related respiratory disease.
abstract: Air pollution in Japan caused respiratory disease, such as chronic bronchitis and asthma, in many individuals in the 1960s. Although air pollution has decreased, many victims of air pollution-related respiratory disease are limited in their activities of daily living because of respiratory symptoms. The purpose of this study was to evaluate the efficacy of pulmonary rehabilitation in victims of air pollution-related chronic bronchitis or asthma. Subjects were enrolled in a 12-week (2-week inpatient followed by 10-week outpatient) pulmonary rehabilitation program. The program comprised conditioning, strength training, endurance training, and patient education. We assessed the Modified Medical Research Council (MMRC) dyspnea grade, pulmonary function, peripheral muscle force, incremental shuttle walk distance (ISWD), and physical activity at baseline and immediately after the program. Twenty-nine subjects (mean age 74.2 ± 10.1 years, 11 males) completed the program, including 11 subjects with COPD and 18 subjects with asthma. Following rehabilitation, the participants (n = 29) showed significant improvements in MMRC dyspnea grade, vital capacity % predicted, quadriceps force and ISWD (all P < 0.05). Sub-group analyses revealed that all these variables were significantly improved in subjects with asthma. In contrast, subjects with COPD showed significant improvements only in quadriceps force and ISWD (both P < 0.05). Thus, pulmonary rehabilitation is an effective method of improving exercise capacity and dyspnea in officially acknowledged victims of air pollution-related asthma. In conclusion, we recommend that patients with chronic bronchitis or asthma, resulting from exposure to air pollution, are referred for pulmonary rehabilitation.
authors.affiliation: Department of Cardiopulmonary Rehabilitation Science, Nagasaki University Graduate School of Biomedical Sciences.
authors.forename: Naomi
authors.initials: N
authors.lastname: Miyamoto
authors.forename: Hideaki
authors.initials: H
authors.lastname: Senjyu
authors.forename: Takako
authors.initials: T
authors.lastname: Tanaka
authors.forename: Masaharu
authors.initials: M
authors.lastname: Asai
authors.forename: Yorihide
authors.initials: Y
authors.lastname: Yanagita
authors.forename: Yudai
authors.initials: Y
authors.lastname: Yano
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Nishinakagawa
authors.forename: Kenji
authors.initials: K
authors.lastname: Kotaki
authors.forename: Chika
authors.initials: C
authors.lastname: Kitagawa
authors.forename: Naoto
authors.initials: N
authors.lastname: Rikitomi
authors.forename: Ryo
authors.initials: R
authors.lastname: Kozu
authors.forename: Sumihisa
authors.initials: S
authors.lastname: Honda
mesh_terms: D000203:Activities of Daily Living; D000368:Aged; D000393:Air Pollutants / Q000009:adverse effects*; D000397:Air Pollution / Q000009:adverse effects; D001249:Asthma / Q000534:rehabilitation* / Q000628:therapy; D004417:Dyspnea / Q000628:therapy*; D015444:Exercise; D005081:Exercise Therapy / Q000379:methods*; D017079:Exercise Tolerance / Q000502:physiology; D005260:Female; D006801:Humans; D007297:Inpatients; D007564:Japan; D008297:Male; D008875:Middle Aged; D010045:Outpatients; D010100:Oxygen / Q000627:therapeutic use; D011446:Prospective Studies; D029424:Pulmonary Disease, Chronic Obstructive / Q000534:rehabilitation* / Q000628:therapy; D011788:Quality of Life; D012129:Respiratory Function Tests
chemical_list: D000393:Air Pollutants; D010100:Oxygen